Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention : rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
収録刊行物
-
- Am Heart J
-
Am Heart J 148 263-268, 2004